Special Senses
Palpitation, vasodilatation, syncope,
Metabolic and Nutritional Disorders
Hemic and Lymphatic System
Ecchymosis,
Postintroduction Reports
Adverse events associated with Lipitor therapy reported since market introduction, that are not listed above, regardless of causality assessment, include the following:
Pediatric Patients (ages 10-17 years)
In a 26-week controlled study in boys and postmenarchal girls (n=140), the
Drug Interactions
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives,
Antacid:
When atorvastatin and Maalox® TC suspension were coadministered,
Antipyrine:
Because atorvastatin does not affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.
Colestipol:
Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and atorvastatin were coadministered. However, LDL-C reduction was greater when atorvastatin and colestipol were coadministered than when either drug was given alone.
